Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 122

1.

Posaconazole Serum Drug Levels Associated with Pseudohyperaldosteronism.

Nguyen MH, Davis MR, Wittenberg R, Mchardy I, Baddley JW, Young BY, Odermatt A, Thompson GR.

Clin Infect Dis. 2019 Aug 12. pii: ciz741. doi: 10.1093/cid/ciz741. [Epub ahead of print]

PMID:
31403165
2.

Factors Associated With Ventriculoperitoneal Shunt Placement in Patients With Cryptococcal Meningitis.

Baddley JW, Thompson GR 3rd, Riley KO, Moore MK, Moser SA, Pappas PG.

Open Forum Infect Dis. 2019 May 20;6(6):ofz241. doi: 10.1093/ofid/ofz241. eCollection 2019 Jun.

3.

Cryptococcosis in solid organ transplantation-Guidelines from the American Society of Transplantation Infectious Diseases Community of Practice.

Baddley JW, Forrest GN; AST Infectious Diseases Community of Practice.

Clin Transplant. 2019 Mar 22:e13543. doi: 10.1111/ctr.13543. [Epub ahead of print]

PMID:
30900315
4.

Effect of Algorithm-Based Therapy vs Usual Care on Clinical Success and Serious Adverse Events in Patients with Staphylococcal Bacteremia: A Randomized Clinical Trial.

Holland TL, Raad I, Boucher HW, Anderson DJ, Cosgrove SE, Aycock PS, Baddley JW, Chaftari AM, Chow SC, Chu VH, Carugati M, Cook P, Corey GR, Crowley AL, Daly J, Gu J, Hachem R, Horton J, Jenkins TC, Levine D, Miro JM, Pericas JM, Riska P, Rubin Z, Rupp ME, Schrank J Jr, Sims M, Wray D, Zervos M, Fowler VG Jr; Staphylococcal Bacteremia Investigators.

JAMA. 2018 Sep 25;320(12):1249-1258. doi: 10.1001/jama.2018.13155.

5.

Two Cases and a Review of Graft-Versus-Host Disease and the Role of Hepatitis C Treatment in Liver Transplant Patients.

Advani SD, Nellore A, Hadjivassiliou G, Eckhoff DE, Salzman D, Lavie D, Pavlidakey P, Baddley JW.

Prog Transplant. 2018 Sep;28(3):267-270. doi: 10.1177/1526924818781558. Epub 2018 Jun 28.

PMID:
29954253
6.

A Mycoses Study Group International Prospective Study of Phaeohyphomycosis: An Analysis of 99 Proven/Probable Cases.

Revankar SG, Baddley JW, Chen SC, Kauffman CA, Slavin M, Vazquez JA, Seas C, Morris MI, Nguyen MH, Shoham S, Thompson GR 3rd, Alexander BD, Simkins J, Ostrosky-Zeichner L, Mullane K, Alangaden G, Andes DR, Cornely OA, Wahlers K, Lockhart SR, Pappas PG.

Open Forum Infect Dis. 2017 Sep 26;4(4):ofx200. doi: 10.1093/ofid/ofx200. eCollection 2017 Fall.

7.

Effect of pulsed xenon ultraviolet room disinfection devices on microbial counts for methicillin-resistant Staphylococcus aureus and aerobic bacterial colonies.

Zeber JE, Pfeiffer C, Baddley JW, Cadena-Zuluaga J, Stock EM, Copeland LA, Hendricks J, Mohammadi J, Restrepo MI, Jinadatha C.

Am J Infect Control. 2018 Jun;46(6):668-673. doi: 10.1016/j.ajic.2018.02.001. Epub 2018 Apr 11.

PMID:
29655672
8.

Pneumocystis and glucocorticoid use: to prophylax or not to prophylax (and when?); that is the question.

Winthrop KL, Baddley JW.

Ann Rheum Dis. 2018 May;77(5):631-633. doi: 10.1136/annrheumdis-2017-212588. Epub 2018 Feb 19. No abstract available.

PMID:
29459427
9.

ESCMID Study Group for Infections in Compromised Hosts (ESGICH) Consensus Document on the safety of targeted and biological therapies: an infectious diseases perspective (Soluble immune effector molecules [I]: anti-tumor necrosis factor-α agents).

Baddley JW, Cantini F, Goletti D, Gómez-Reino JJ, Mylonakis E, San-Juan R, Fernández-Ruiz M, Torre-Cisneros J.

Clin Microbiol Infect. 2018 Jun;24 Suppl 2:S10-S20. doi: 10.1016/j.cmi.2017.12.025. Epub 2018 Feb 6. Review.

10.

Human polyomavirus-7-associated eruption successfully treated with acitretin.

Canavan TN, Baddley JW, Pavlidakey P, Tallaj JA, Elewski BE.

Am J Transplant. 2018 May;18(5):1278-1284. doi: 10.1111/ajt.14634. Epub 2018 Jan 21.

11.

Association of baseline steroid use with long-term rates of infection and sepsis in the REGARDS cohort.

Chaudhary NS, Donnelly JP, Moore JX, Baddley JW, Safford MM, Wang HE.

Crit Care. 2017 Jul 13;21(1):185. doi: 10.1186/s13054-017-1767-1.

12.

Longterm Effectiveness of Herpes Zoster Vaccine among Patients with Autoimmune and Inflammatory Diseases.

Yun H, Xie F, Baddley JW, Winthrop K, Saag KG, Curtis JR.

J Rheumatol. 2017 Jul;44(7):1083-1087. doi: 10.3899/jrheum.160685. Epub 2017 Mar 15.

13.

Application of the Third International Consensus Definitions for Sepsis (Sepsis-3) Classification: a retrospective population-based cohort study.

Donnelly JP, Safford MM, Shapiro NI, Baddley JW, Wang HE.

Lancet Infect Dis. 2017 Jun;17(6):661-670. doi: 10.1016/S1473-3099(17)30117-2. Epub 2017 Mar 4.

14.

Safety of Biologic and Nonbiologic Disease-modifying Antirheumatic Drug Therapy in Veterans with Rheumatoid Arthritis and Hepatitis C Virus Infection.

Burton MJ, Curtis JR, Yang S, Chen L, Singh JA, Mikuls TR, Winthrop KL, Baddley JW.

J Rheumatol. 2017 May;44(5):565-570. doi: 10.3899/jrheum.160983. Epub 2017 Mar 1.

PMID:
28250142
15.

Association of Diabetes and Insulin Therapy With Risk of Hospitalization for Infection and 28-Day Mortality Risk.

Donnelly JP, Nair S, Griffin R, Baddley JW, Safford MM, Wang HE, Shapiro NI.

Clin Infect Dis. 2017 Feb 15;64(4):435-442. doi: 10.1093/cid/ciw738.

16.

Opportunistic Infections in Biological Therapy, Risk and Prevention.

Bryant PA, Baddley JW.

Rheum Dis Clin North Am. 2017 Feb;43(1):27-41. doi: 10.1016/j.rdc.2016.09.005. Epub 2016 Oct 22. Review.

PMID:
27890172
17.

The risk of hospitalized infection following initiation of biologic agents versus methotrexate in the treatment of juvenile idiopathic arthritis.

Beukelman T, Xie F, Baddley JW, Chen L, Mannion ML, Saag KG, Zhang J, Curtis JR.

Arthritis Res Ther. 2016 Sep 22;18(1):210.

18.

The epidemiology and outcomes of invasive Candida infections among organ transplant recipients in the United States: results of the Transplant-Associated Infection Surveillance Network (TRANSNET).

Andes DR, Safdar N, Baddley JW, Alexander B, Brumble L, Freifeld A, Hadley S, Herwaldt L, Kauffman C, Lyon GM, Morrison V, Patterson T, Perl T, Walker R, Hess T, Chiller T, Pappas PG; TRANSNET Investigators.

Transpl Infect Dis. 2016 Dec;18(6):921-931. doi: 10.1111/tid.12613. Epub 2016 Nov 14.

PMID:
27643395
19.

Herpes Zoster and the Risk of Stroke in Patients With Autoimmune Diseases.

Calabrese LH, Xie F, Yun H, Winthrop KL, Baddley JW, Calabrese C, Curtis JR.

Arthritis Rheumatol. 2017 Feb;69(2):439-446. doi: 10.1002/art.39855.

20.

Hemostasis biomarkers and risk of sepsis: the REGARDS cohort.

Moore JX, Zakai NA, Mahalingam M, Griffin RL, Irvin MR, Safford MM, Baddley JW, Wang HE.

J Thromb Haemost. 2016 Nov;14(11):2169-2176. doi: 10.1111/jth.13446. Epub 2016 Sep 23.

21.

Inpatient Mortality Among Solid Organ Transplant Recipients Hospitalized for Sepsis and Severe Sepsis.

Donnelly JP, Locke JE, MacLennan PA, McGwin G Jr, Mannon RB, Safford MM, Baddley JW, Muntner P, Wang HE.

Clin Infect Dis. 2016 Jul 15;63(2):186-94. doi: 10.1093/cid/ciw295. Epub 2016 May 23.

22.

Risk of Herpes Zoster in Autoimmune and Inflammatory Diseases: Implications for Vaccination.

Yun H, Yang S, Chen L, Xie F, Winthrop K, Baddley JW, Saag KG, Singh J, Curtis JR.

Arthritis Rheumatol. 2016 Sep;68(9):2328-37. doi: 10.1002/art.39670.

23.

Approach to the Solid Organ Transplant Patient with Suspected Fungal Infection.

Anesi JA, Baddley JW.

Infect Dis Clin North Am. 2016 Mar;30(1):277-96. doi: 10.1016/j.idc.2015.10.001. Epub 2015 Dec 28. Review.

24.

Isavuconazole versus voriconazole for primary treatment of invasive mould disease caused by Aspergillus and other filamentous fungi (SECURE): a phase 3, randomised-controlled, non-inferiority trial.

Maertens JA, Raad II, Marr KA, Patterson TF, Kontoyiannis DP, Cornely OA, Bow EJ, Rahav G, Neofytos D, Aoun M, Baddley JW, Giladi M, Heinz WJ, Herbrecht R, Hope W, Karthaus M, Lee DG, Lortholary O, Morrison VA, Oren I, Selleslag D, Shoham S, Thompson GR 3rd, Lee M, Maher RM, Schmitt-Hoffmann AH, Zeiher B, Ullmann AJ.

Lancet. 2016 Feb 20;387(10020):760-9. doi: 10.1016/S0140-6736(15)01159-9. Epub 2015 Dec 10.

PMID:
26684607
25.

Hospital-onset Clostridium difficile infection among solid organ transplant recipients.

Donnelly JP, Wang HE, Locke JE, Mannon RB, Safford MM, Baddley JW.

Am J Transplant. 2015 Nov;15(11):2970-7. doi: 10.1111/ajt.13491.

26.

Opportunistic infections and biologic therapies in immune-mediated inflammatory diseases: consensus recommendations for infection reporting during clinical trials and postmarketing surveillance.

Winthrop KL, Novosad SA, Baddley JW, Calabrese L, Chiller T, Polgreen P, Bartalesi F, Lipman M, Mariette X, Lortholary O, Weinblatt ME, Saag M, Smolen J.

Ann Rheum Dis. 2015 Dec;74(12):2107-16. doi: 10.1136/annrheumdis-2015-207841. Epub 2015 Sep 22. Review.

PMID:
26395500
27.

Comparative Risk of Hospitalized Infection Associated With Biologic Agents in Rheumatoid Arthritis Patients Enrolled in Medicare.

Yun H, Xie F, Delzell E, Levitan EB, Chen L, Lewis JD, Saag KG, Beukelman T, Winthrop KL, Baddley JW, Curtis JR.

Arthritis Rheumatol. 2016 Jan;68(1):56-66. doi: 10.1002/art.39399.

28.

Loss of Vancomycin-Resistant Enterococcus Fecal Dominance in an Organ Transplant Patient With Clostridium difficile Colitis After Fecal Microbiota Transplant.

Stripling J, Kumar R, Baddley JW, Nellore A, Dixon P, Howard D, Ptacek T, Lefkowitz EJ, Tallaj JA, Benjamin WH Jr, Morrow CD, Rodriguez JM.

Open Forum Infect Dis. 2015 Jun 3;2(2):ofv078. doi: 10.1093/ofid/ofv078. eCollection 2015 Apr.

29.

Ocular bartonellosis in transplant recipients: two case reports and review of the literature.

Lee RA, Ray M, Kasuga DT, Kumar V, Witherspoon CD, Baddley JW.

Transpl Infect Dis. 2015 Oct;17(5):723-7. doi: 10.1111/tid.12418. Epub 2015 Jul 31. Review.

PMID:
26146758
30.

Safety of biologic and nonbiologic disease-modifying antirheumatic drug therapy in veterans with rheumatoid arthritis and hepatitis B virus infection: a retrospective cohort study.

Burton MJ, Curtis JR, Yang S, Chen L, Singh JA, Mikuls TR, Winthrop KL, Baddley JW.

Arthritis Res Ther. 2015 May 22;17:136. doi: 10.1186/s13075-015-0628-z.

31.

Prospective multicenter international surveillance of azole resistance in Aspergillus fumigatus.

van der Linden JW, Arendrup MC, Warris A, Lagrou K, Pelloux H, Hauser PM, Chryssanthou E, Mellado E, Kidd SE, Tortorano AM, Dannaoui E, Gaustad P, Baddley JW, Uekötter A, Lass-Flörl C, Klimko N, Moore CB, Denning DW, Pasqualotto AC, Kibbler C, Arikan-Akdagli S, Andes D, Meletiadis J, Naumiuk L, Nucci M, Melchers WJ, Verweij PE.

Emerg Infect Dis. 2015 Jun;21(6):1041-4. doi: 10.3201/eid2106.140717.

32.

Phaeohyphomycosis in transplant recipients: Results from the Transplant Associated Infection Surveillance Network (TRANSNET).

McCarty TP, Baddley JW, Walsh TJ, Alexander BD, Kontoyiannis DP, Perl TM, Walker R, Patterson TF, Schuster MG, Lyon GM, Wingard JR, Andes DR, Park BJ, Brandt ME, Pappas PG; TRANSNET Investigators.

Med Mycol. 2015 Jun;53(5):440-6. doi: 10.1093/mmy/myv018. Epub 2015 Apr 23.

PMID:
25908651
33.

Discharge diagnoses versus medical record review in the identification of community-acquired sepsis.

Wang HE, Addis DR, Donnelly JP, Shapiro NI, Griffin RL, Safford MM, Baddley JW.

Crit Care. 2015 Feb 16;19:42. doi: 10.1186/s13054-015-0771-6.

34.

Mollaret's meningitis.

Min Z, Baddley JW.

Lancet Infect Dis. 2014 Oct;14(10):1022. doi: 10.1016/S1473-3099(14)70874-6. No abstract available.

PMID:
25253408
35.

Risks of herpes zoster in patients with rheumatoid arthritis according to biologic disease-modifying therapy.

Yun H, Xie F, Delzell E, Chen L, Levitan EB, Lewis JD, Saag KG, Beukelman T, Winthrop K, Baddley JW, Curtis JR.

Arthritis Care Res (Hoboken). 2015 May;67(5):731-6. doi: 10.1002/acr.22470.

36.

Pneumocystis jirovecii pneumonia in patients receiving tumor-necrosis-factor-inhibitor therapy: implications for chemoprophylaxis.

Grubbs JA, Baddley JW.

Curr Rheumatol Rep. 2014 Oct;16(10):445. doi: 10.1007/s11926-014-0445-4. Review.

PMID:
25182673
37.

Race and invasive fungal infection in solid organ transplant recipients.

Boehme AK, McGwin G, Andes DR, Lyon GM, Chiller T, Pappas PG, Baddley JW.

Ethn Dis. 2014 Summer;24(3):382-5.

PMID:
25065083
38.

Transmission of Balamuthia mandrillaris through solid organ transplantation: utility of organ recipient serology to guide clinical management.

Gupte AA, Hocevar SN, Lea AS, Kulkarni RD, Schain DC, Casey MJ, Zendejas-Ruiz IR, Chung WK, Mbaeyi C, Roy SL, Visvesvara GS, da Silva AJ, Tallaj J, Eckhoff D, Baddley JW.

Am J Transplant. 2014 Jun;14(6):1417-24. doi: 10.1111/ajt.12726. Epub 2014 May 19.

39.

Reply to "acute sinusitis and pharyngitis as inappropriate indications for antibiotic use".

Donnelly JP, Baddley JW, Wang HE.

Antimicrob Agents Chemother. 2014 Jun;58(6):3573. doi: 10.1128/AAC.02779-14. No abstract available.

40.

Epidemiology of invasive mold infections in lung transplant recipients.

Doligalski CT, Benedict K, Cleveland AA, Park B, Derado G, Pappas PG, Baddley JW, Zaas DW, Harris MT, Alexander BD.

Am J Transplant. 2014 Jun;14(6):1328-33. doi: 10.1111/ajt.12691. Epub 2014 Apr 11.

41.

A case report of progressive multifocal leucoencephalopathy (PML) associated with adalimumab.

Ray M, Curtis JR, Baddley JW.

Ann Rheum Dis. 2014 Jul;73(7):1429-30. doi: 10.1136/annrheumdis-2013-204978. Epub 2014 Mar 11. No abstract available.

PMID:
24618264
42.

Risk of hospitalised infection in rheumatoid arthritis patients receiving biologics following a previous infection while on treatment with anti-TNF therapy.

Yun H, Xie F, Delzell E, Chen L, Levitan EB, Lewis JD, Saag KG, Beukelman T, Winthrop K, Baddley JW, Curtis JR.

Ann Rheum Dis. 2015 Jun;74(6):1065-71. doi: 10.1136/annrheumdis-2013-204011. Epub 2014 Mar 7.

43.

Endemic fungal infections in solid organ and hematopoietic cell transplant recipients enrolled in the Transplant-Associated Infection Surveillance Network (TRANSNET).

Kauffman CA, Freifeld AG, Andes DR, Baddley JW, Herwaldt L, Walker RC, Alexander BD, Anaissie EJ, Benedict K, Ito JI, Knapp KM, Lyon GM, Marr KA, Morrison VA, Park BJ, Patterson TF, Schuster MG, Chiller TM, Pappas PG.

Transpl Infect Dis. 2014 Apr;16(2):213-24. doi: 10.1111/tid.12186. Epub 2014 Mar 4.

44.

Risk of hospitalized bacterial infections associated with biologic treatment among US veterans with rheumatoid arthritis.

Curtis JR, Yang S, Patkar NM, Chen L, Singh JA, Cannon GW, Mikuls TR, Delzell E, Saag KG, Safford MM, DuVall S, Alexander K, Napalkov P, Winthrop KL, Burton MJ, Kamauu A, Baddley JW.

Arthritis Care Res (Hoboken). 2014 Jul;66(7):990-7. doi: 10.1002/acr.22281.

45.

Histoplasmosis in patients with human immunodeficiency virus/acquired immunodeficiency syndrome (HIV/AIDS): multicenter study of outcomes and factors associated with relapse.

Myint T, Anderson AM, Sanchez A, Farabi A, Hage C, Baddley JW, Jhaveri M, Greenberg RN, Bamberger DM, Rodgers M, Crawford TN, Wheat LJ.

Medicine (Baltimore). 2014 Jan;93(1):11-8. doi: 10.1097/MD.0000000000000016.

46.

Antibiotic utilization for acute respiratory tract infections in U.S. emergency departments.

Donnelly JP, Baddley JW, Wang HE.

Antimicrob Agents Chemother. 2014;58(3):1451-7. doi: 10.1128/AAC.02039-13. Epub 2013 Dec 16.

47.

Immunosuppression regimen and the risk of acute rejection in HIV-infected kidney transplant recipients.

Locke JE, James NT, Mannon RB, Mehta SG, Pappas PG, Baddley JW, Desai NM, Montgomery RA, Segev DL.

Transplantation. 2014 Feb 27;97(4):446-50. doi: 10.1097/01.TP.0000436905.54640.8c.

PMID:
24162248
48.

Sexual history taking and sexually transmitted infection screening in patients initiating erectile dysfunction medication therapy.

Holman KM, Carr JA, Baddley JW, Hook EW 3rd.

Sex Transm Dis. 2013 Nov;40(11):836-8. doi: 10.1097/OLQ.0000000000000031.

PMID:
24113402
49.

Infectious complications of immune modulatory agents.

La Hoz RM, Baddley JW.

Curr Infect Dis Rep. 2013 Dec;15(6):465-71. doi: 10.1007/s11908-013-0365-x.

PMID:
24072569
50.

Histoplasmosis after solid organ transplant.

Assi M, Martin S, Wheat LJ, Hage C, Freifeld A, Avery R, Baddley JW, Vergidis P, Miller R, Andes D, Young JA, Hammoud K, Huprikar S, McKinsey D, Myint T, Garcia-Diaz J, Esguerra E, Kwak EJ, Morris M, Mullane KM, Prakash V, Burdette SD, Sandid M, Dickter J, Ostrander D, Antoun SA, Kaul DR.

Clin Infect Dis. 2013 Dec;57(11):1542-9. doi: 10.1093/cid/cit593. Epub 2013 Sep 17.

Supplemental Content

Loading ...
Support Center